An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway
Abstract Background Sepsis-associated encephalopathy (SAE) is characterized by diffuse brain dysfunction, long-term cognitive impairment, and increased morbidity and mortality. The current treatment for SAE is mainly symptomatic; the lack of specific treatment options and a poor understanding of the...
المؤلفون الرئيسيون: | , , , , , , , , , , , , |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
BMC
2023-07-01
|
سلاسل: | Journal of Translational Medicine |
الموضوعات: | |
الوصول للمادة أونلاين: | https://doi.org/10.1186/s12967-023-04345-7 |